Consistent prebiotic effect on gut microbiota with altered fodmap intake in patients with crohn s disease: A randomised, controlled cross-over trial of well-defined diets

Clinical and Translational Gastroenterology

Volumn 7, Issue 4, 2016, Pages

  Halmos, Emma P ^a   Christophersen, Claus T ^b,c   Bird, Anthony R ^b   Shepherd, Susan J ^a,d   Muir, Jane G ^a   Gibson, Peter R ^a  

^a MONASH UNIVERSITY   (Australia)

^b CSIRO   (Australia)

^c EDITH COWAN UNIVERSITY   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BALSALAZIDE; CALGRANULIN; DISACCHARIDE; INFLIXIMAB; MESALAZINE; MONOSACCHARIDE; OLIGOSACCHARIDE; POLYOL; PREBIOTIC AGENT; SHORT CHAIN FATTY ACID;

ABDOMINAL PAIN; ADULT; AKKERMANSIA MUCINIPHILA; ARTICLE; AUSTRALIAN DIET; BACTERIUM; BLOATING; BUTYRATE PRODUCING CLOSTRIDIUM; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CLOSTRIDIUM; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; CROSSOVER PROCEDURE; DIET; DIETARY COMPLIANCE; DISEASE SEVERITY; FAECALIBACTERIUM PRAUSNITZII; FALLING; FECES ANALYSIS; FECES MICROFLORA; FEMALE; GASTROINTESTINAL SYMPTOM; HABITUAL DIET; HARVEY BRADSHAW INDEX; HUMAN; INTESTINE FLORA; IRRITABLE COLON; LOW FODMAP DIET; MALE; NONHUMAN; PH; POPULATION ABUNDANCE; RANDOMIZED CONTROLLED TRIAL; RUMINOCOCCUS; WIND;

EID: 85014020112     PISSN: 2155384X     EISSN: None     Source Type: Journal    
DOI: 10.1038/ctg.2016.22     Document Type: Article

References (36)

1. Tuck CJ, Muir JG, Barrett JS et al. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome. Expert Rev Gastroenterol Hepatol 2014; 8: 819 834.
2. de Roest RH, Dobbs BR, Chapman BA et al. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: A prospective study. Int J Clin Pract 2013; 67: 895 903.
3. Ong DK, Mitchell SB, Barrett JS et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010; 25: 1366 1373.
4. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc 2006; 106: 1631 1639.
5. Staudacher HM, Whelan K, Irving PM et al. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet 2011; 24: 487 495.
6. Halmos EP, Power VA, Shepherd SJ et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterol 2014; 146: 67 75.
7. Farrokhyar F, Marshall JK, Easterbrook B et al. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: Prevalence and impact on health. Inflamm Bowel Dis 2006; 12: 38 46.
8. Gearry RB, Irving PM, Barrett JS et al. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease a pilot study. J Crohns Colitis 2009; 3: 8 14.
9. Staudacher H, Lomer MCE, Anderson J et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012; 142: 1510 1518.
10. Halmos EP, Christophersen CT, Bird AR et al. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015; 64: 93 100.
11. Joossens M, Huys G, Cnockaert M et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011; 60: 631 637.
12. Png C, Linden S, Gilshenan K et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 2010; 105: 2420 2428.
13. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980; 315: 514.
14. Biesiekierski JR, Peters SL, Newnham ED et al. No effects of gluten in patients with selfreported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterol 2013; 145: 320 328.
15. Shepherd SJ, Parker FC, Muir JG et al. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008; 6: 765 771.
16. Barrett JS, Gibson PR. Development and validation of a comprehensive semi-quantitative food frequency questionnaire that includes FODMAP intake and glycemic index. J Am Diet Assoc 2010; 110: 1469 1476.
17. NHMRC. Australian dietary guidelines. In: Department of Health and Ageing. Canberra, Australia 2013.
18. Gudmand Hoyer E, Simony K. Individual sensitivity to lactose in lactose malabsorption. Am J Dig Dis 1977; 22: 177 181.
19. Bird AR, Flory C, Davies DA et al. A novel barley cultivar (Himalaya 292) with a specific gene mutation in starch synthase IIa raises large bowel starch and short-chain fatty acids in rats. J Nutr 2004; 134: 831 835.
20. Yu Z, Morrison M. Improved extraction of PCR-quality community DNA from digesta and fecal samples. Biotechniques 2004; 36: 808 812.
21. Sokol H, Pigneur B, Watterlot L et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008; 105: 16731 16736.
22. Hansen R, Russell RK, Reiff C et al. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacteral diversity in Crohn's but not in ulcerative colitis. Am J Gastroenterol 2012; 107: 1913 1922.
23. Hedin C, van der Gast CJ, Rogers GB et al. Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities. Gut 2015 (e-pub ahead of print).
24. Derrien M, Van Baarien P, Hooiveld G et al. Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Front Microbiol 2011; 2: 166.
25. Lukovac S, Belzer C, Pellis L et al. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. MBio 2014; 5: e01438-14.
26. Yao CK, Tan HL, van Langenberg DR et al. Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome. J Hum Nutr Diet 2013; 27 (Suppl 2): 263 275.
27. Bouhnik Y, Raskine L, Simoueau G et al. The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: A dose-response relationship study in healthy humans. Nutr J 2006; 5: 8.
28. Lindsay JO, Whelan K, Stagg AJ et al. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut 2006; 55: 348 355.
29. Walton M, Alaunyte I. Do patients living with ulcerative colitis adhere to healthy eating guidelines? A cross-sectional study. Brit J Nutr 2014; 112: 1628 1635.
30. Anderson JL, Hedin CR, Benjamin JL et al. Dietary intake of inulin-Type fructans in active and inactive Crohn's disease and healthy controls: A case-control study. J Crohns Colitis 2015; 9: 1024 1031.
31. Derrien M, Vaughan E, Plugge C. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 2004; 54: 1469 1476.
32. Hamer HM, Jonkers D, Venema K et al. Review article: The role of butyrate on colonic function. Aliment Pharmacol Ther 2008; 27: 104 119.
33. Scheppach W. Treatment of distal ulcerative colitis with short-chain fatty acid enemas. A placebo-controlled trial. German-Austrian SCFA Study Group. Dig Dis Sci 1996; 41: 2254 2259.
34. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001; 81: 1031 1064.
35. Kassinen A, Krogius-Kurikka L, Makivuokko H et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterol 2007; 133: 24 33.
36. Matto J, Maunuksela L, Kajander K et al. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 2005; 43: 213 222.